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Abstract 
Introduction: Recurrent pneumococcal meningitis is a relatively rare condition associated with 
predisposing factors. The objective of the study was to evaluate the characteristics and predisposing 
factors for recurrent pneumococcal meningitis in adults and compare them to patients with non-recurrent 
meningitis. Methods: A retrospective record review was performed of all patients hospitalized for 
pneumococcal meningitis in a large tertiary referral center, during a 10-year period. Results: We identified 
a total of 194 pneumococcal meningitis episodes in 182 patients. Thirty-eight (20%) meningitis episodes 
in 26 patients were recurrent. Anatomical defects and/or CSF leakage were present in 55% of recurrent 
pneumococcal meningitis vs. 10% of non-recurrent episodes (p<0.001). Impaired immune response 
was encountered in 41% non-recurrent meningitis vs 24% of recurrent episodes (p=0.02). Median 
age in patients with recurrent meningitis was 29 years, while patients with non-recurrent meningitis 
had a median age of 57 years (p<0.001). The in-hospital mortality was 3% in patients with recurrent 
meningitis vs 27% in patients with non-recurrent meningitis (p<0.001). An unfavorable outcome was 
more likely to occur in patients with advanced age and an impaired immune status.
Conclusions: Patients with recurrent pneumococcal meningitis were younger, had less comorbidities 
and a better outcome.
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immunodeficiency.2-4 Recurrent pneumococcal 
meningitis is not a common occurrence but it 
is a challenging condition and requires further 
investigations to identify predisposing factors in 
order to prevent further episodes and improve the 
overall outcomes. Although better described in 
children, there are only few studies on recurrent 
meningitis in adults. Predisposing conditions 
associated with recurrent bacterial meningitis can 
be divided into chronic parameningeal infections 
and congenital or acquired anatomical defects and 
immunodeficiencies.
 The objective of this study was to analyze 
the underlying predisposing conditions and in-
hospital mortality of adult patients with recurrent 
pneumococcal meningitis and compare them to 
non-recurrent cases during a 10 year-period.
METHODS
We conducted a retrospective record review of 
all patients hospitalized between January 2005 
INTRODUCTION
Recurrent bacterial meningitis is defined as two or 
more episodes of meningitis caused by the same 
organism and occurring at least 3 weeks after 
completion of therapy for the initial episode, or at 
least two episodes caused by different organisms 
irrespective of the time interval between the 
episodes. Thus, recurrent bacterial meningitis is 
differentiated from relapse in which the initial 
infection is persisting.1 The incidence of bacterial 
recurrent meningitis was estimated at 5-6% of the 
community-acquired meningitis.2,3 More than half 
of cases are due to Streptococcus pneumoniae, 
followed by Neisseria meningitidis, which causes 
one quarter of the episodes.1
 S. pneumoniae is the leading cause of acute 
bacterial meningitis in adults, with a mortality of 
15–34%.2 It is the most frequently isolated organism 
in conditions associated with abnormal cerebrospinal 
fluid (CSF) flow or cranial bone defects, and in 
patients with underlying congenital or acquired 
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and December 2015 for pneumococcal meningitis 
at the National Institute of Infectious Diseases 
“Prof. Dr. Matei Bals” from Bucharest, Romania, 
a large referral hospital specialized in infectious 
diseases. Electronic medical records were 
searched for patients diagnosed with meningitis 
during the study period. The patient files were 
retrieved and cases of pneumococcal meningitis 
were selected. The diagnosis of pneumococcal 
meningitis was established based on the presence 
of clinical signs and symptoms of meningitis and 
the detection of S. pneumoniae from CSF or blood 
samples in combination with cerebrospinal fluid 
abnormalities (pleocytosis, elevated protein levels 
and decreased CSF/serum glucose ratio < 0.5). 
Microbiological confirmation of pneumococcal 
infection was made based on typical morphology 
on Gram-stain, a positive CSF latex agglutination 
reaction, and/or a positive culture for S. 
pneumoniae (CSF or blood culture). Recurrent 
pneumococcal meningitis was defined as at least 
two pneumococcal meningitis episodes occurring 
at least 4 weeks after the completion of treatment 
for the initial episode followed by full recovery. 
We excluded relapsing meningitis resulting from 
treatment failure (defined as the persistence of 
the initial infection) or healthcare associated 
infections (such as following neurosurgery, 
otorhino-laryngological interventions or other 
forms of cranial or maxillofacial surgery).
 We recorded data on socio-demographic 
status, clinical features, predisposing conditions 
associated with pneumococcal meningitis 
and in-hospital mortality. Patient records 
were evaluated for the presence of any of the 
following diagnoses: otitis, mastoiditis, sinusitis, 
pneumonia, endocarditis, inner ear abnormalities, 
congenital skull base defects, head injury/
basal skull fracture, CSF fistulas or conditions 
associated with immunodeficiency (diabetes 
mellitus, alcohol abuse, end-stage liver disease, 
advanced chronic kidney disease, malignancy, 
malnutrition, splenectomy, autoimmune 
disorders or immunosuppressive therapy). 
Immunosuppressive drugs were considered: 
glucocorticosteroids at a higher cumulative dose 
of 700 mg or prednisone at a higher dose than 
20 mg/day, chemotherapy drugs, monoclonal 
antibodies, or drugs acting on immunophilins. 
There was no follow-up of patients after discharge 
and therefore no data on long-term sequelae was 
available. 
 We analyzed data using the Statistical Package 
for Social Sciences (SPSS version 21, IBM Corp., 
Armonk, NY, USA). Dichotomous variables were 
compared by the Chi-squared test. Continuous 
variables were compared by the Mann-Whitney 
U test and p < 0.05 was considered significant. 
RESULTS
We identified a total of 194 pneumococcal 
meningitis episodes in 182 patients diagnosed 
and treated in our institution between January 
2005 and December 2015. Thirty-eight (20%) 
episodes of recurrent meningitis were recorded 
in 26 patients and 156 (80%) episodes of non-
recurrent meningitis. Sixteen (8.8%) out of 182 
patients with recurrent meningitis experienced two 
episodes, 5 patients (2.7%) had three episodes and 
there were 5 patients with four, five, seven, 11 and 
40 prior recurrent episodes. We included in this 
analysis only episodes considered as “recurrent 
meningitis” according to the aforementioned 
definition and occurring during the study period.
 The demographic characteristics of our patients 
and the underlying conditions predisposing 
to recurrent or non-recurrent pneumococcal 
meningitis are shown in Table 1. 
 Bone defects and/or CSF leakage in recurrent 
and non-recurrent pneumococcal meningitis 
groups were: inner ear abnormalities in one case 
in both groups, congenital skull base defects in 
8 (21%) versus and 3 (2%) cases, head injury/
basal skull fracture in 4 (11%) and 5 (3%) cases, 
CSF fistulas in 8 (21%) and 6 (4%) of cases, 
respectively. Hematogenous spread from a primary 
infectious site was observed only in patients from 
the non-recurrent meningitis group: 10 (71%) 
cases with lower respiratory tract infections and 4 
(29%) cases with endocarditis. Other predisposing 
factors in patients with non-recurrent meningitis 
were immunodeficiency (in most cases acquired). 
Other conditions associated with an increased 
risk of pneumococcal meningitis in patients with 
recurrent and non-recurrent meningitis: diabetes 
mellitus in 1 (3%) and 31 (20%) cases, alcohol 
abuse in 2 (5%) and 14 (9%) cases, end-stage 
liver disease in 0 and 7 (4%) cases, malignancy 
in 2 (5%) and 7 (4%) cases, malnutrition in 1 
(3%) and 4 (3%) cases, splenectomy in 0 and 
1 (1%) case, immunosuppressive therapy in 0 
and 2 (1%) cases respectively (1 patient was on 
anti-TNF therapy and the other received 60 mg 
of prednisone/day). Overall, conditions associated 
with an impaired immune response were present 
in 70 patients (38%).
 The median time from onset of disease until 
admission was 2.5 days (IQR 1.5-3.2) in the 
recurrent meningitis groups versus 2.4 days 
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(IQR:1.8-3.6) in the non-recurrent meningitis 
group (p = 0.8). Focal neurological deficits were 
represented by pyramidal signs and cranial nerve 
palsies. Seizures were found in 5 cases in the 
recurrent meningitis group (13%) and in 7 cases 
(5%) in the non-recurrent meningitis group (p 
= 0.06; OR 3.6, 95% CI: 0.9-14.1). Impaired 
consciousness on admission was seen in 15 cases 
(39%) in the recurrent meningitis group versus 
64 cases (41 %) in the other group (p = 0.6; OR 
0.78, 95% CI: 0.26-2.28).
 In hospital mortality was 27% in the non-
recurrent meningitis group versus 3% in the 
recurrent meningitis group (p< 0.001; OR 0.07, 
95% CI: 0.01-0.5). Risk factors associated with 
in-hospital mortality in both groups are shown in 
Table 2.
DISCUSSION
This study describes the characteristics and 
predisposing factors for recurrent pneumococcal 
meningitis in adults from a large tertiary referral 
center in Bucharest, Romania and compares them 
to those of patients without recurrent meningitis. 
 In this study, recurrent meningitis represented 
20% of community-acquired pneumococcal 
meningitis cases. Other authors reported that 
between 2.3% and 12.8% of cases of community-
acquired meningitis in adults are recurrent, S. 
pneumoniae being the most frequent etiology.1-3,5 
The high proportion of recurrent meningitis in this 
study might be due to the fact that the hospital 
where the study was conducted is a referral center 
where complex cases are being treated, while 
many patients with non-recurrent meningitis are 
admitted to smaller centers.
Table 1: Characteristics of patients with recurrent and non-recurrent pneumococcal meningitis 
 Recurrent Non-recurrent  p value
 meningitis meningitis OR (95% CI)
 N=38 N=156 
Age, median (IQR)  29 (21-47) 57 (38-65) < 0.001
Male gender, n (%) 19 (50) 90 (58) 0.2
   1.3 (0.6-2.7)
Bone defects and/or CSF leakage, n (%) 21 (55) 15 (10) < 0.001
   14.4 (6.2-33.4)
Sinusitis, n (%) 7 (18) 18 (12) 0.19
   1.7 (0.6-4.5)
Otitis/ mastoiditis, n (%) 2 (5) 47 (30) 0.003
   0.2 (0.05-0.68)
Hematogenous spread, n (%) 0 14 (9) 0.04
   0.9 (0.8-0.95)
Impaired immune response, n (%) 8 (21) 62 (40) 0.02
   0.4 (0.1-0.9) 
CSF cerebrospinal fluid, IQR interquartile range, OR odds ratio.
Table 2: Risk factors associated with in-hospital mortality in patients with pneumococcal meningitis
 Deceased Discharged alive p-value
 N=43 N=151 
Age, median (IQR) 59 (47-66) 49 (28-62) 0.02
Hematogenous spread, n (%) 3 (7) 11 (7.2) 0.9
Impaired immune responsea, n (%) 24 (56) 52 (34.5) 0.01
Neurological symptomsb, n (%) 19 (44) 60 (40) 0.5
Recurrent meningitis, n (%) 1 (3) 37 (97) < 0.001
aImpaired immune response: diabetes mellitus, alcohol abuse, end-stage liver disease, malignancy, malnutrition, 
splenectomy, immunosuppressive therapy, pregnancy, autoimmunedisorders, advancedchronickidneydisease. 
bNeurologic symptoms: impaired consciousness on admission, cranial nerve palsies, seizures and/or focal neurologic 
deficits).
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 Most studies on recurrent meningitis describe 
cases with two episodes.3,5-7 In one study, up to 
84% of patients with recurrent bacterial meningitis 
experienced only two episodes.3 However, one of 
the patients included in this study had experienced 
no less than 40 previous episodes8 and other 
authors report a case with 12 recurrent episodes in 
a patient with a minor head injury and a skull base 
defect.9 The case of the patient who experienced 
40 recurrent pneumococcal meningitis episodes 
had been published elsewhere.8 The recurrences 
of bacterial meningitis were due to CSF leakage 
and the presence of chronic sinusitis. In this 
patient the recurrences were not influenced 
by the surgical repair of a fistula and repeated 
surgical draining interventions on suppurating 
chronic sinusitis. Long-term prophylaxis with 
phenoxymethylpenicillin reduced the number of 
recurrences and there were no further episodes 
following anti-pneumococcal vaccination for a 
5-year period.
 In this study, recurrent meningitis was not 
more common in men, in contrast to previous 
reports.1,3,5,7 More frequent recurrent meningitis 
in men might be related to a higher frequency of 
head trauma.3
 We found a significant age difference between 
patients with recurrent meningitis, who were 
younger as compared with the patients from the 
non-recurrent group. This is consistent with data 
reported by others.1,3,10,11
 In this study, anatomical defects associated with 
CSF leakage were a major predisposing factor for 
developing recurrent pneumococcal meningitis. 
Cranial skull defects are a well-recognized risk 
factor for S. pneumoniae-recurrent meningitis in 
adults, especially following head trauma.1-3,5,12,13 
In a review of 363 cases of recurrent bacterial 
meningitis, 214 episodes (59%) were related to 
anatomical defects, in which the abnormality was 
located in the majority of cases in the cranial 
or cervical region. Traumatic head injury with 
secondary CSF fistulae, accounted for almost 
half of all cases in this group (47%).1 In another 
study, the most common predisposing conditions 
for recurrent bacterial meningitis were prior head 
injury in 53% of 32 episodes and CSF leakage in 
32% of 28 episodes.3
 Predisposing conditions for non-recurrent 
pneumococcal meningitis, especially in patients 
with an impaired immune response led to 
dissemination of infection from a contiguous 
site (especially otitis and mastoiditis) and 
hematogenous spread. This is consistent with data 
reported by one review of 493 episodes of acute 
bacterial meningitis in adults which included 404 
single episodes.2 In our study, a small number 
of cases in the recurrent group were related to 
an immunosuppressive condition. This was also 
found by other authors, where only 9% of 34 
patients were immunosuppressed.3
 In-hospital mortality due to pneumococcal 
meningitis was associated with immunosuppression 
and impaired consciousness on admission. There 
was only one death in the recurrent meningitis 
group which prevented us to analyze the risk 
factors associated with mortality. In our study, 
there was a significant difference in mortality 
between recurrent and non-recurrent meningitis, 
with 3% versus 27%, respectively, which is 
similar with other reports. In a cohort from 
the Netherlands the mortality in patients with 
non-recurrent meningitis was more than double 
compared with patients with recurrent meningitis 
(34 vs. 15%).3,11 In another study of patients 
from the US which included 38 episodes of 
recurrent community-acquired meningitis and 
253 community acquired single episodes over 
a 27-year period, the overall mortality rates 
(per patient) were 6% for recurrent community-
acquired meningitis and 25% in patients 
admitted for their first episode.2 The difference 
in mortality between the groups, beyond their age 
and underlying conditions, might be due to the 
fact that patients who had experienced previous 
episodes of meningitis are likely to recognize the 
symptoms early and seek medical attention sooner, 
being referred from the onset of symptoms to a 
specialized tertiary health-care hospital, thereby 
improving their prognosis. This could be an 
explanation also reported by another study.3
 The limitations of our study are related to 
its retrospective nature, to the fact that only in-
hospital mortality could be evaluated, while long-
term morbidity (including neurological sequelae) 
and mortality were not assessed. Additionally, 
serotyping for S. pneumoniae and information on 
antipneumococcal vaccination were not available. 
However, we present data from a relatively 
large cohort of 182 patients with pneumococcal 
meningitis.
 In conclusion, this study showed that patients 
with recurrent pneumococcal meningitis were 
younger, had less co-morbidities and a better 
outcome compared with patients with non-
recurrent meningitis. Overall, an unfavorable 
course was more likely to occur in patients with 
advanced age and an impaired immune status. It 
is important to diagnose underlying predisposing 
conditions in patients with recurrent meningitis 
in order to prevent further episodes. 
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